Healthcare & Life Sciences

memodio

aliveseed
seed
Stage
2
Investors

About

Memodio is a clinically developed digital therapeutic app prescribed by clinicians in Germany that combines cognitive training, physical exercise, and everyday support to help individuals with mild cognitive impairment or mild dementia maintain daily functioning and slow disease progression.

Explore memodio's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.